Opinion
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are often choosing between two bad options: restricting access or raising consumer costs.
Wednesday, November 30, 2022. Graham has battled excess weight for years, cycling through trendy diets, various drugs, and even bariatric surgery. she started a new medication, Mounjaro ...
Hosted on MSN5mon
New weight loss drug that could burn fat twice as fast as OzempicA new weight loss drug could see patients lose double the amount ... Wegovy and Mounjaro in the last three months of 2022, with companies racing to expand supply to meet the demand.
Whether millions of people will be able to afford one of the hot new weight-loss drugs ... trial in 2022 to test ...
Eli Lilly & Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the U.S., ...
New weight-loss jabs could help boost the economy in Britain by getting people “back into work”, the Prime Minister has said.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback